Medicare Enrolled

Dr. Charles Gibson, M.D.

Interventional Cardiology · Boston, MA
Practice pattern: Interventional Cardiology — Practice focused on catheter-based cardiac procedures
Consulting-driven
350 LONGWOOD AVE, Boston, MA 02115
6175256884
In practice since 2006 (20 years)
NPI: 1124053277 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Gibson from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Gibson? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Gibson

Dr. Charles Gibson is an interventional cardiology specialist in Boston, MA, with 20 years of NPI registration. Based on federal Medicare data, Dr. Gibson performed 43 Medicare services across 43 unique beneficiaries.

Between the years covered by Open Payments, Dr. Gibson received a total of $980,096 from 37 pharmaceutical and/or device companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in interventional cardiology. The majority of payments are for consulting, which typically reflects recognized clinical expertise sought by manufacturers. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Gibson is Very High — reflecting how much public federal data is available about this provider. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 20 years in practice ▲ 43 Medicare services $980,096 industry payments

Medicare Practice Summary

Medicare Utilization ↗
43
Medicare services
Bottom 7% in MA for interventional cardiology
Lower Medicare volume may reflect subspecialty focus, hospital-based work, or a higher share of non-Medicare patients.
43
Unique beneficiaries
$72
Avg. Medicare payment
Medicare patients only (65+ / disabled) · How to read this →
~2 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Sedation by physician, initial 15 minutes
Administration of a drug to induce depression of consciousness by the physician performing a procedure. This code covers the initial 15 minutes of sedation for patients aged 5 years or older.
 26 $10 $41
Coronary angiography
A procedure to insert a tube into a coronary artery to capture diagnostic images of the heart's blood vessels.
 17 $167 $773
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.

Industry Payment Transparency

Open Payments through 2024 ↗
$980,096
Total received (2018-2024)
Avg $140,014/year across 7 years
Top 0% in MA for interventional cardiology
A higher payment rank reflects disclosed industry relationships (consulting, research, speaking) common among subspecialists — not wrongdoing.
37
Companies
297
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Consulting
Expert advisory fees, typically reflecting recognized clinical expertise
$550,821 (56.2%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$350,899 (35.8%)
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$78,377 (8.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$132,787
2023
$85,062
2022
$104,876
2021
$40,595
2020
$72,182
2019
$162,695
2018
$381,899

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Avertix Medical, Inc
$30,000
HEARTFLOW, INC.
$24,955
ROCHE DIAGNOSTICS INTERNATIONAL LTD
$16,226
Daiichi Sankyo Inc.
$13,585
E.R. Squibb & Sons, L.L.C.
$13,000
Amgen Inc.
$11,031
CSL Behring
$9,972
Boston Scientific Corporation
$9,375
Esperion Therapeutics, Inc.
$3,164
Boehringer Ingelheim International GmbH
$1,480
Top 3 companies account for 53.6% of 2024 payments
All-time payments by company (2018-2024) ›
Portola Pharmaceuticals, Inc.
$258,628
Janssen Research & Development, LLC
$135,429
CSL Behring
$73,175
Avertix Medical, Inc
$60,000
Daiichi Sankyo Inc.
$46,282
Amarin Pharma Inc.
$38,201
Amgen Inc.
$31,066
Janssen Pharmaceuticals, Inc
$30,157
PORTOLA PHARMACEUTICALS, INC.
$27,114
E.R. Squibb & Sons, L.L.C.
$26,150
HEARTFLOW, INC.
$24,955
INTERCEPT PHARMACEUTICALS, INC.
$23,800
Bayer HealthCare Pharmaceuticals Inc.
$23,285
Boston Scientific Corporation
$21,433
Janssen Scientific Affairs, LLC
$18,750
ROCHE DIAGNOSTICS INTERNATIONAL LTD
$16,226
AMAG Pharmaceuticals, Inc.
$15,776
SANOFI US SERVICES INC.
$15,643
Janssen Global Services, LLC
$15,403
The Medicines Company
$11,350
Haemonetics Corporation
$10,039
Merck Sharp & Dohme Corporation
$10,000
PFIZER INC.
$8,740
Merck Sharp & Dohme LLC
$7,819
BOSTON SCIENTIFIC CORPORATION
$5,700
Genentech, Inc.
$4,799
Novartis Pharmaceuticals Corporation
$4,752
NOVARTIS PHARMACEUTICALS CORPORATION
$3,960
Esperion Therapeutics, Inc.
$3,164
SANOFI-AVENTIS U.S. LLC
$2,932
Novo Nordisk Inc
$2,322
Boehringer Ingelheim International GmbH
$1,480
AstraZeneca Pharmaceuticals LP
$1,074
HeartFlow, Inc.
$393
Siemens Medical Solutions USA, Inc.
$38
Medtronic, Inc.
$35
CeloNova BioSciences, Inc.
$25
Top 3 companies account for 47.7% of all-time payments
Associated products mentioned in payments ›
APOLLOTM · BEVYXXA · BRILINTA · Bevyxxa · CELEBREX · CLINICAL TRIAL PRODUCT · CorPath GRX · ELIQUIS · EVENITY · FERAHEME · FFRct · JARDIANCE · LEQVIO · NEXLETOL · NO PRODUCT DISCUSSED · Non-Covered · Ozempic · PAXLOVID · PRALUENT · Plasma · Repatha · Savaysa · TEG · TEG6s HEMOSTASIS SYSTEM · TNKase · Vascepa · WATCHMAN · WATCHMAN Access System · WATCHMAN FLX · XARELTO
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

The majority of payments (56%) are consulting fees, which typically reflect recognized clinical expertise sought by manufacturers. Total industry engagement is in the top 0% for interventional cardiology in MA.

Looking for an interventional cardiology specialist in Boston?
Compare interventional cardiologists in the Boston area by procedure volume, costs, and industry payment transparency.
Browse interventional cardiologists nearby

Geographic Context

Interventional cardiologists within 10 mi
38
Per 100K population
4.9
County median income
$92,859
Nearest hospital
BRIGHAM AND WOMEN'S HOSPITAL
0.0 mi

Data Sources

Provider Registry ✓ NPPES Weekly updates
Medicare Enrollment ✓ PECOS Monthly updates
Practice Data ✓ Medicare Util. Annual (CY lag)
Industry Payments ✓ Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This reflects how much public data is available about a provider. How we calculate this →

Summary

Dr. Gibson is an interventional cardiology specialist, with moderate Medicare volume, with consulting-driven industry engagement in the top 0% of MA peers, with 20 years of NPI registration.

This summary is auto-generated from federal data, describing data availability and patterns. Read our methodology →

Frequently Asked Questions

Is Dr. Gibson experienced with sedation by physician, initial 15 minutes?
Based on Medicare claims data, Dr. Gibson performed 26 sedation by physician, initial 15 minutes services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Gibson receive payments from pharmaceutical companies?
Yes. Dr. Gibson received a total of $980,096 from 37 companies across 297 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Gibson's costs compare to other interventional cardiologists in Boston?
Dr. Gibson's average Medicare payment per service is $72. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Gibson) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →

Explore related providers

Same specialty & city
Interventional Cardiologists in Boston
Browse interventional cardiologists in Boston ranked by procedure volume and transparency data.
Highest volume
Top Interventional Cardiologists in MA
Interventional cardiologists ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Interventional Cardiologists in MA
Which MA interventional cardiologists receive the most from drug and device companies.
By company
Portola Pharmaceuticals, Inc. Payments to Doctors
See all physicians who received payments from Portola Pharmaceuticals, Inc.
By company
Janssen Research & Development, LLC Payments to Doctors
See all physicians who received payments from Janssen Research & Development, LLC.
By company
CSL Behring Payments to Doctors
See all physicians who received payments from CSL Behring.
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. Data Coverage reflects data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →